Teruto Hashiguchi
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research 18
- Immunology top 5%
- Immune Response and Inflammation 7
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 6
- Hematology top 2%
- Platelet Disorders and Treatments 8
- Pharmacology top 2%
- Cannabis and Cannabinoid Research 7
- Neurology top 5%
-
- Angiogenesis and VEGF in Cancer 11
-
- Retinal Diseases and Treatments 8
-
- Blood properties and coagulation 6
- Co-authors
- Ikuro MaruyamaKoichi KawaharaMunekazu YamakuchiMitsuhiro OsameKimiyoshi ArimuraShingo YamadaTakashi ItoKamal Krishna Biswas
- Journals
- Biochemical and Biophysical Research Communications (9 papers)Laboratory Investigation (4 papers)PLoS ONE (4 papers)
- Partner nations
- JapanUnited StatesThailand
In The Last Decade
Teruto Hashiguchi
127 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 129
- Clinical Biochemistry 636
- Immunology 781
- Hematology 365
- Pharmacology 493
- Neurology 216
Countries citing papers authored by Teruto Hashiguchi
This map shows the geographic impact of Teruto Hashiguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teruto Hashiguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teruto Hashiguchi more than expected).
Fields of papers citing papers by Teruto Hashiguchi
This network shows the impact of papers produced by Teruto Hashiguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teruto Hashiguchi. The network helps show where Teruto Hashiguchi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Teruto Hashiguchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 4 | |
| 3 | 2020 | 9 | |
| 4 | 2019 | 4 | |
| 5 | 2018 | 12 | |
| 6 | 2017 | 11 | |
| 7 | The use of hyaluronan in phacoemulsification protects human corneal endothelial cells from the noxious effect of extracellular histones. | 2014 | 2 |
| 8 | 2014 | 2 | |
| 9 | 2013 | 14 | |
| 10 | 2013 | 44 | |
| 11 | 2012 | 24 | |
| 12 | 2010 | 19 | |
| 13 | 2010 | 38 | |
| 14 | 2009 | 88 | |
| 15 | 2009 | 17 | |
| 16 | 2009 | 48 | |
| 17 | 2007 | 13 | |
| 18 | 2004 | 20 | |
| 19 | 2001 | 103 | |
| 20 | 2000 | 81 |
About Teruto Hashiguchi
Teruto Hashiguchi is a scholar working on Clinical Biochemistry, Internal Medicine and Hematology, having authored 131 papers that have together received 4.0k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (18 papers), Angiogenesis and VEGF in Cancer (11 papers), Retinal Diseases and Treatments (8 papers), Platelet Disorders and Treatments (8 papers), Cannabis and Cannabinoid Research (7 papers), Immune Response and Inflammation (7 papers), Blood properties and coagulation (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers). The work is most often cited by research in Clinical Biochemistry (636 citations), Immunology (781 citations) and Hematology (365 citations). Teruto Hashiguchi has collaborated with scholars based in Japan, United States and Thailand. Frequent co-authors include Ikuro Maruyama, Koichi Kawahara, Munekazu Yamakuchi, Mitsuhiro Osame, Kimiyoshi Arimura, Shingo Yamada, Takashi Ito, Kamal Krishna Biswas, Ko-ichi Kawahara and Kazuhiro Abeyama. Their work appears in journals such as Biochemical and Biophysical Research Communications, Laboratory Investigation, PLoS ONE, Blood and Journal of Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.